Compare Freeport-McMoRan Inc (FCX) vs Nutrien Ltd (NTR) Price & Performance

Freeport-McMoRan (FCX) trades at $71.87, down 0.97% on the day, with strong technical momentum indicated by bullish moving averages. The company has beaten earnings estimates for three consecutive quarters, with Q3 2026 results expected shortly. FCX maintains solid profitability with 11.38% net margin and 15.37% ROE, supported by robust operational cash flow of $5.61 billion in 2025. Recent news highlights copper's strategic importance for AI infrastructure, positioning FCX to benefit from long-term demand trends.

FCX presents a compelling opportunity with analyst consensus at Buy (61%) and $73.27 price target, offering 2% upside. The company's expansion projects and copper's AI-driven demand create growth potential, though rising production costs and ongoing legal investigation pose risks. Institutional sentiment remains positive given FCX's market leadership and favorable commodity outlook.

Nutrien (NTR) trades at $69.97, down 1.73% with bearish technical signals despite recent earnings beats. The stock shows mixed fundamentals with revenue stabilizing around $26-28B and net margins improving to 8.44%. Recent news highlights industry headwinds from potential Belarus potash imports, though strong fertilizer prices and cost discipline support cash flow. Analyst consensus remains moderately bullish with a $76.14 price target, representing 9% upside potential from current levels.

Investment outlook balances cyclical fertilizer demand against structural advantages. Near-term risks include competitive pressure from potential Belarus imports and sulfur cost inflation, but North American gas arbitrage and agricultural cycle recovery provide catalysts. With reasonable valuation (P/E 14.16) and 60% analyst buy ratings, the stock offers value for patient investors despite technical weakness.